Safety concerns blight promising cancer therapy

Heidi Ledford

Nature, 2016, vol. 538, issue 7624, 150-151

Abstract: As the first T-cell therapies for tumours near US approval, researchers race to engineer less-toxic alternatives.

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/538150a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:538:y:2016:i:7624:d:10.1038_538150a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/538150a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().